Mirum Pharmaceuticals, Inc. (MIRM)
82.39
+2.43
(+3.04%)
USD |
NASDAQ |
Oct 15, 16:00
82.28
-0.12
(-0.14%)
After-Hours: 20:00
Mirum Pharmaceuticals Cash from Operations (TTM) : -227.27M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -227.27M |
| March 31, 2026 | -170.98M |
| December 31, 2025 | 55.83M |
| September 30, 2025 | 44.69M |
| June 30, 2025 | 8.995M |
| March 31, 2025 | -6.848M |
| December 31, 2024 | 10.32M |
| September 30, 2024 | -1.225M |
| June 30, 2024 | -23.43M |
| March 31, 2024 | -21.96M |
| December 31, 2023 | -70.94M |
| September 30, 2023 | -88.60M |
| June 30, 2023 | -96.40M |
| March 31, 2023 | -114.24M |
| Date | Value |
|---|---|
| December 31, 2022 | -120.14M |
| September 30, 2022 | -119.01M |
| June 30, 2022 | -127.19M |
| March 31, 2022 | -147.22M |
| December 31, 2021 | -132.76M |
| September 30, 2021 | -135.89M |
| June 30, 2021 | -119.14M |
| March 31, 2021 | -95.93M |
| December 31, 2020 | -89.08M |
| September 30, 2020 | -66.49M |
| June 30, 2020 | -64.26M |
| March 31, 2020 | -55.29M |
| December 31, 2019 | -39.36M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Incyte Corp. | 1.980B |
| Insmed, Inc. | -778.92M |
| Galectin Therapeutics, Inc. | -15.89M |
| Kodiak Sciences, Inc. | -158.50M |
| Praxis Precision Medicines, Inc. | -305.24M |